Using oncology care pathways and treatment pathways has helped practices use evidence-based data to facilitate them to be sure they are using the right drug for the right patient at the right time, said Ray Page, DO, PhD, president and director of research at The Center for Cancer and Blood Disorders.
Using oncology care pathways and treatment pathways has helped practices use evidence-based data to facilitate them to be sure they are using the right drug for the right patient at the right time, said Ray Page, DO, PhD, president and director of research at The Center for Cancer and Blood Disorders.
Transcript
How are physicians using data at the point-of-care today?
We’re trying to increasingly use that kind of data at the point of care to help make behavior modifications for our physicians to help us identify some of these risk stratifiers that are occurring. Certainly 1 thing that our practice has done for many years is just the utilization of oncology care pathways and treatment pathways, and just being able to use that kind of evidence-based data to facilitate us in assuring that we’re using the right drug for the right patient at the right time, it goes a long way just utilizing treatments pathways.
I’ll emphasize also that as we find these quality measures and these benchmarks and these standards and these interventions that this is very much a team approach and as we take care of our cancer patients and get them through the journey with their cancer, we do have an entire team that manages those. There’s certain data elements that occur at the physician level that we manage but then there’s other data elements that will go to our advanced practitioners to manage.
Then there’s other data elements and processes that occur that go to our case managers and our triage nurses and our chemotherapy nurses and then all of our ancillary services that we have so that we can actually utilize everybody in the team to function at their highest level to assure that our patients are getting all the touches and the contacts that they need in order to have optimal outcomes.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More